Canon Medical Systems Corporation, a Japan-based developer of medical diagnostic imaging systems and medical solutions, has acquired Fysicon B.V., a developer of healthcare information systems in the Netherlands, for an undisclosed consideration.
Fysicon is a developer and assembler of innovative medical software and hardware for hospitals, clinics and research institutes. Since its foundation in 1996 and with unique advanced technologies and clinical evidence, Fysicon has developed and manufactured product families such as cardiovascular monitoring systems.
Canon Medical Systems Corporation develops medical diagnostic imaging systems and medical solutions. It offers angiography, computed tomography, magnetic resonance, ultrasound, X-ray, nuclear medicine, healthcare imaging informatics systems and RF amplifier components. The company was founded in 1930 and is headquartered in Otawara-shi, Japan, with subsidiaries in Japan, North America, South America, Europe, Africa, the Mid-East, Asia, and Oceania.
Oaklins' healthcare team in the Netherlands advised the selling shareholder throughout the process.
Bert Elberse, founder of Fysicon, commented: “Oaklins's team guided us through the transaction with a professional approach, but never lost sight of the sensitivities of a family business. Their expertise and deep industry knowledge was key to achieving a successful outcome. They did a tremendous job from start to finish – beginning with expert company positioning and well crafted marketing materials and ending with outstanding process management. On top of that, the team is a pleasure to work with."
Fysicon's CEO Linda Elberse, added: "Working together has been very productive and we always had a great time. Now we are ready to take our business to the next level, and we truly appreciate the Dutch team's role in helping to make it happen."
© 2019 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.